ArticleJournal of neurology2026

Serum biomarkers remain stable after transitioning from intravenous to subcutaneous natalizumab in multiple sclerosis.

Albert Muñoz-Vendrell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.